Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.08 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |